Methimazole Side Effects
Patients taking methimazole must be warned about potentially life-threatening agranulocytosis and instructed to immediately stop the medication and contact their physician if they develop fever, sore throat, mouth sores, pharyngitis, or malaise 1, 2.
Major (Life-Threatening) Side Effects
Agranulocytosis
- Occurs in 0.15-0.45% of patients 3
- 95% of cases occur within the first 100 days of therapy 1, 3
- Dose-dependent with methimazole, rarely occurs at low doses 1
- Routine white blood cell monitoring is NOT recommended because onset is sudden and unpredictable 1
- Obtain differential white blood cell count immediately during any febrile illness or at onset of pharyngitis 1
- Absolute contraindication to switch to propylthiouracil if agranulocytosis develops (50% cross-reactivity risk) 3
Hepatotoxicity
- Less common than with propylthiouracil, but can occur 2
- Presents with anorexia, pruritus, jaundice, pale stools, dark urine, right upper quadrant pain 1
- Stop medication if transaminases exceed 3 times upper limit of normal 2
- Moderate transaminase elevation (14-28% of patients) usually normalizes spontaneously in first 2 months 3
Vasculitis
- ANCA-positive vasculitis can occur 1, 2
- Manifestations include: leukocytoclastic cutaneous vasculitis, acute kidney injury, glomerulonephritis, pulmonary hemorrhage, CNS vasculitis, neuropathy 2
- Discontinue immediately if vasculitis suspected and initiate corticosteroids/immunosuppression as needed 2
First Trimester Teratogenicity
- Contraindicated in first trimester of pregnancy 2
- Causes aplasia cutis, choanal atresia, esophageal atresia, omphalocele, facial dysmorphism 2
Minor Side Effects
Cutaneous Reactions (5-10% of patients)
- Pruritic rash, urticaria 1, 3
- Can manage with concurrent antihistamines without stopping the drug 1
- If persistent, switch to radioactive iodine, surgery, or propylthiouracil (if other options refused) 1
Arthralgias/Myalgias (1-5% of patients)
- Joint or muscle/tendon pain 3
- Can be disabling despite being "minor" 3
- May be inaugural symptom of vasculitis—monitor closely 3
Gastrointestinal
- Abdominal pain, nausea, anorexia 1
Other Common Effects
Monitoring Algorithm
Before Starting Treatment
- Baseline complete blood count with differential 1
- Baseline liver function tests (bilirubin, transaminases, alkaline phosphatase) 1
During Treatment
- No routine white blood cell monitoring recommended 1
- Check CBC immediately if fever, pharyngitis, mouth sores, or malaise develop 1
- Stop medication if absolute neutrophil count <1,000/mm³ (some suggest <800/mm³) 3
- Monitor thyroid function tests monthly initially, then every 2-4 months 1
Critical Patient Education Points
Patients must be instructed at EVERY visit to stop medication immediately and call physician if they develop 1:
- Fever or sore throat (agranulocytosis)
- Jaundice, pale stools, or dark urine (hepatotoxicity)
- Pruritic rash
- Arthralgias
- Abdominal pain
- Nausea or fatigue
- Pharyngitis or mouth sores
Special Populations
Children
- Same side effect profile as adults 1
- Younger age and lower baseline neutrophil count are risk factors for neutropenia 4
- Most adverse reactions occur within 3 months of starting treatment 4
Pregnancy
- Use propylthiouracil in first trimester instead 1
- Can use methimazole in second and third trimesters at lowest effective dose 2